KORTHOSCompaniesProductsVerified EventsSupply Chain

Company profile

Microbot Medical

Microbot Medical develops robotic systems for endovascular procedures. Its LIBERTY robotic platform is designed to let physicians remotely control single-u...

Facts

Segment
SURGICAL
Country
United States
Headquarters
Hingham, MA
Ticker
MBOT
Website
https://www.microbotmedical.com/

About Microbot Medical

Microbot Medical develops LIBERTY, a remotely operated robotic system for peripheral endovascular procedures. A physician uses a compact controller to manipulate compatible guidewires and catheters from outside the immediate radiation field, while a single-use robotic drive unit mounts beside the patient and interfaces with conventional procedure-room equipment.

The system received US FDA clearance in 2025 and entered a limited commercial release followed by a broader US launch in 2026. Hospitals use LIBERTY in vascular interventions without installing a large fixed robotic console, and the disposable patient-side unit removes reprocessing between cases. Microbot is expanding clinical training and hospital adoption while gathering operating experience across its initial commercial sites.

Market context

DEPLOYMENT

Summary

Type: Surgical robotics

Core: LIBERTY

Function: Surgery

Audience: Healthcare providers

Products

Research, Articles and recent verified events